SPY313.44-2.74 -0.87%
DIA257.39-3.34 -1.28%
IXIC10,465.67-26.83 -0.26%

UPDATE: JP Morgan Upgrades Teva To Neutral, Notes 'We remain fairly bearish on the longer-term setup for the company between its lack of growth-drivers (Ajovy underperforming expectations so far, lingering LOEs, etc.) and still high-leverage'

Do you like seeing these details as to why an analyst recommended a stock? What could we do to make this product better? Let us know by emailing newsdesk@benzinga.com

Benzinga · -